Hoy J - Search Results

1

Effect of rosiglitazone on peroxisome proliferator-activated receptor gamma gene expression in human adipose tissue is limited by antiretroviral drug-induced mitochondrial dysfunction.

Mallon PW, Sedwell R, Rogers G, Nolan D, Unemori P, Hoy J, Samaras K, Kelleher A, Emery S, Cooper DA, Carr A; Rosey Investigators. Mallon PW, et al. Among authors: hoy j. J Infect Dis. 2008 Dec 15;198(12):1794-803. doi: 10.1086/593179. J Infect Dis. 2008. PMID: 18954260 Clinical Trial.

2

Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial.

Carr A, Workman C, Smith DE, Hoy J, Hudson J, Doong N, Martin A, Amin J, Freund J, Law M, Cooper DA; Mitochondrial Toxicity (MITOX) Study Group. Carr A, et al. Among authors: hoy j. JAMA. 2002 Jul 10;288(2):207-15. doi: 10.1001/jama.288.2.207. JAMA. 2002. PMID: 12095385 Clinical Trial.

3

Thymidine analogue withdrawal for lipoatrophic patients on protease-sparing therapy improves lipoatrophy but compromises antiviral control: the PIILR extension study.

Smith DE, Carr A, Law M, Martin A, Hudson J, Hoy J, Cooper DA. Smith DE, et al. Among authors: hoy j. AIDS. 2002 Dec 6;16(18):2489-91. doi: 10.1097/00002030-200212060-00020. AIDS. 2002. PMID: 12461429 Clinical Trial. No abstract available.

4

Limited evolution of HIV antiretroviral drug resistance-associated mutations during the performance of drug resistance testing.

Birch C, Middleton T, Hales G, Cooper D, Law M, Crowe S, Hoy J, Emery S. Birch C, et al. Among authors: hoy j. J Acquir Immune Defic Syndr. 2003 Jan 1;32(1):57-61. doi: 10.1097/00126334-200301010-00008. J Acquir Immune Defic Syndr. 2003. PMID: 12514414

5

Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study.

Martin A, Smith DE, Carr A, Ringland C, Amin J, Emery S, Hoy J, Workman C, Doong N, Freund J, Cooper DA; Mitochondrial Toxicity Study Group. Martin A, et al. Among authors: hoy j. AIDS. 2004 Apr 30;18(7):1029-36. doi: 10.1097/00002030-200404300-00011. AIDS. 2004. PMID: 15096806 Clinical Trial.

6

Progression of lipodystrophy (LD) with continued thymidine analogue usage: long-term follow-up from a randomized clinical trial (the PIILR study).

Martin A, Smith D, Carr A, Hoy J, Chuah J, Mallal S, Law M, Clements M, Cooper DA; PIILR Study Group. Martin A, et al. Among authors: hoy j. HIV Clin Trials. 2004 Jul-Aug;5(4):192-200. doi: 10.1310/0GU7-6X27-MMHE-5ALE. HIV Clin Trials. 2004. PMID: 15472793 Free article. Clinical Trial.

7

Long-term patterns in CD4 response are determined by an interaction between baseline CD4 cell count, viral load, and time: The Asia Pacific HIV Observational Database (APHOD).

Egger S, Petoumenos K, Kamarulzaman A, Hoy J, Sungkanuparph S, Chuah J, Falster K, Zhou J, Law MG; Asia Pacific HIV Observational Database (APHOD). Egger S, et al. Among authors: hoy j. J Acquir Immune Defic Syndr. 2009 Apr 15;50(5):513-20. doi: 10.1097/qai.0b013e31819906d3. J Acquir Immune Defic Syndr. 2009. PMID: 19408354 Free PMC article.

8

The effects of intermittent, CD4-guided antiretroviral therapy on body composition and metabolic parameters.

Martinez E, Visnegarwala F, Grund B, Thomas A, Gibert C, Shlay J, Drummond F, Pearce D, Edwards S, Reiss P, El-Sadr W, Carr A; INSIGHT SMART study group. Martinez E, et al. AIDS. 2010 Jan 28;24(3):353-63. doi: 10.1097/QAD.0b013e3283333666. AIDS. 2010. PMID: 20057309 Free PMC article. Clinical Trial.

9

Changes in lipids and lipoprotein particle concentrations after interruption of antiretroviral therapy.

Lampe FC, Duprez DA, Kuller LH, Tracy R, Otvos J, Stroes E, Cooper DA, Hoy J, Paton NI, Friis-Møller N, Neuhaus J, Liappis AP, Phillips AN; INSIGHT SMART Study Group. Lampe FC, et al. Among authors: hoy j. J Acquir Immune Defic Syndr. 2010 Jul;54(3):275-84. doi: 10.1097/qai.0b013e3181d32158. J Acquir Immune Defic Syndr. 2010. PMID: 20658749 Free PMC article. Clinical Trial.

10

Efavirenz versus boosted atazanavir or zidovudine and abacavir in antiretroviral treatment-naive, HIV-infected subjects: week 48 data from the Altair study.

Puls RL, Srasuebkul P, Petoumenos K, Boesecke C, Duncombe C, Belloso WH, Molina JM, Li L, Avihingsanon A, Gazzard B, Cooper DA, Emery S; Altair Study Group. Puls RL, et al. Clin Infect Dis. 2010 Oct 1;51(7):855-64. doi: 10.1086/656363. Clin Infect Dis. 2010. PMID: 20735258 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

469 results

Search Page